Earnings Releases·Nov 5, 2026, 6:47 AM ET

Cardinal Health — First Quarter Fiscal Year 2027 Earnings Summary

Revenue increased 5% year-over-year to $67.5 billion, while GAAP diluted EPS rose 27% to $2.38 and Non-GAAP diluted EPS increased 28% to $3.26.
The company raised its full-year FY27 Non-GAAP diluted EPS guidance to $12.80–$13.00 and increased segment profit growth guidance for Pharmaceutical and Specialty Solutions to 10%–12% and Other to 17%–20%.
Pharmaceutical and Specialty Solutions segment profit grew 17% to $783 million, whereas Global Medical Products and Distribution segment profit declined 28% to $33 million due to unfavorable distribution and foreign exchange impacts.
Strategic capital allocation included a $500 million accelerated share repurchase completed in Q1, while the company entered a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.
Management anticipates completing the acquisition of AdaptHealth's Diabetes Health business in Q3 FY27 and secured an additional $1.0 billion in uncommitted revolving credit facilities.